2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Early Onset Hyperuricemia Is a Prognostic Marker for Kidney Allograft Dysfunction.

M. Han,¹ S. Yang,² I. Jung,³ S.-K. Park,⁴ Y. Kim,⁵ D. Han,⁵ Y. Kim,¹ S. Kim,⁶ J. Lee.⁷
Early Post Renal Transplant aHUS in Patients with Heterozygous CFHR3-CFHR1 Deletion.

S. Rhazouani, A. Malone, T. Alhamad, T. Maw, D. Brennan, R. Delos Santos.
Early Post-Transplant Immunosuppression (IS) Withdrawal – Final Outcomes of the ITN030ST AWISH Study.

A. Shaked,¹ S. Feng,² J. Punch,³ J. Reyes,⁴ J. Levitsky,⁵ G. Klintmalm,⁶ H. Kopetskie,⁷ M. DesMarais,² A. Priore,⁸ N. Bridges,⁸ P. Sayre.²
Early Post-Transplant Patient, Graft Survival and Rejection Rates Under KAS.

A. Kucheryavaya, D. Stewart, D. Klassen.
Early Posttransplant Complications Following Abo-Incompatible Kidney Transplantation.

L. Rostaing,^1,2,3 A. Allal,¹ H. Naciri Benami,¹ Z. Abdulrahman,¹ L. Esposito,¹ F. Sallusto,¹ N. Doumerc,¹ X. Game,¹ B. Debiol,¹ N. Congy,¹ N. Kamar.^1,3,4
Early Proteomic Predictors of Late Chronic Kidney Disease in Liver Transplant Recipients.

J. Levitsky,¹ S. Asrani,² L. Zhao,¹ M. Abecassis,¹ L. Jennings,² G. Klintmalm.²
Early Steroid Withdrawal in African American Kidney Transplant Recipients: A Propensity Score Matching Analysis.

D. Taber, M. Gebregziabher, T. Srinivas, K. Chavin, P. Baliga, L. Egede.
Early Tacrolimus Exposure in Patients Treated De Novo with Once-Daily Tacrolimus After Liver Transplantation: Relationship with Acute Rejection and Long-Term Outcome.

M. Gastaca, A. Valdivieso, J. Bustamante, P. Ruiz, J. Fernandez, A. Ventoso, M. Testillano, I. Palomares, M. Prieto, P. Salvador, A. Matarranz, M. Suarez, J. Ortiz de Urbina.
Eary Use of Statins Associated with Improved Death-Censored Graft Survival Following Kidney Transplant.

T. Horwedel,¹ D. Brennan,² K. Lentine,³ J. Hagopian.¹
EBV Sero-Positivity Does Not Reduce the Risk for EBV Viremia and/or Post-Transplant Lymphoproliferative Disorder (PTLD) in Patients (Pts) Receiving Belatacept (CTLA4Ig).

J. Choi, B. Shin, J. Kahwaji, S. Ge, D. Thomas, A. Vo, O. Galera, R. Villicana, A. Peng, S. Jordan, M. Toyoda.

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z